Modulatory effect of berberine on adipose tissue PPARγ, adipocytokines and oxidative stress in high fat diet/ streptozotocin-induced diabetic rats

Journal of Applied Pharmaceutical Science

Volumn 7, Issue 4, 2017, Pages 1-10

  Mahmoud, Ayman M ^a   Abdel Rahman, Marwa M ^b   Bastawy, Nermin A ^b   Eissa, Hassan M ^b  

^a Beni Suef University   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Berberine; Diabetes; High fat diet; Inflammation; Oxidative stress; PPAR ; Resistin

Indexed keywords

EID: 85018996130     PISSN: None     EISSN: 22313354     Source Type: Journal    
DOI: 10.7324/JAPS.2017.70401     Document Type: Article

References (83)

1. Ahmed OM, Abdel-Moneim A, Abulyazid I, Mahmoud AM. Antihyperglycemic, antihyperlipidemic and antioxidant effects and the probable mechanisms of action of Rutagraveolens and rutin in nicotinamide/streptozotocin diabetic albino rats. Diabetol Croat. 2010;39(1):15-32
2. Ahmed OM, Mahmoud AM, Abdel-Moneim A, Ashour MB. Antidiabetic effects of hesperidin and naringin in type 2 diabetic rats. Diabetol Croat. 2012;41(2):53-67
3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33(Suppl.1): S62-S69
4. Aragno M, Mastrocola R, Catalano MG, Brignardello E, Danni O, Boccuzzi G. Oxidative stress impairs skeletal muscle repair in diabetic rats. Diabetes. 2004;53:1082-8
5. Arulselvan P, Subramanian SP. Beneficial effects of Murrayakoenigii leaves on antioxidant defense system and ultrastructural changes of pancreatic β-cells in experimental diabetes in rats. ChemBiol Interact. 2007;165: 155-64
6. Attie AD, Scherer PE. Adipocyte metabolism and obesity. J Lipid Res. 2009;50:395-9
7. Bastard JP, Pieroni L, Hainque B. Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance. Diabetes Metab Res Rev. 2000;16:192-201
8. Beck-Nielsen H. Insulin resistance: organ manifestations and cellular mechanisms. UgeskrLaeger. 2002;164:2130-5
9. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. The J Lab Clin Med. 1963;61:882-8
10. Blüher M1. Adipose tissue dysfunction in obesity. ExpClinEndocrinol Diabetes. 2009;117: 241-50
11. Chang W, Zhang M, Li J, Meng Z, Wei S, Du H, Chen L, Hatch GM. Berberine improves insulin resistance in cardiomyocytesvia activation of 5'-adenosine monophosphate-activated protein kinase. Metabolism. 2013;62(8):1159-67
12. Cheng F, Wang Y, Li J, Su C, Wu F, Xia WH, Yang Z, Yu BB, Qiu YX, Tao J. Berberine improves endothelial function by reducing endothelial microparticles-mediated oxidative stress in humans. Int J Cardiol. 2013;167(3):936-42
13. Cho BJ, Im EK, Kwon JH, Lee KH, Shin HJ, Oh J, Kang SM, Chung JH, Jang Y. Berberine inhibits the production of lysophosphatidylcholine-induced reactive oxygen species and the ERK1/2 pathway in vascular smooth muscle cells. Mol Cell, 2005;20:429-34
14. Choi BH, Ahn IS, Kim YH, Park JW, Lee SY, Hyun CK, Do MS. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte. ExpMol Med. 2006;38:599-605
15. Chueh WH, Lin JY. Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice. J Agric Food Chem, 2011;59:8021-7
16. Chueh WH, Lin JY. Protective effect of berberine on serum glucose levels in non-obese diabetic mice. IntImmunopharmacol. 2012;12:534-8
17. Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem. 1970;34(1):30-8
18. Donnelly JG. Carbohydrates and alterations in glucose metabolism. In: Bishop ML, Fody EP, editors. Clinical chemistry (principles, procedures, correlations). Philadelphia: Lippincott, 1996; 308-9
19. Elgawish A, Glomb M, Freelander M, Monnier VM. Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem. 1996;271:12964-71
20. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes. 2003;52:1-8
21. Farswan M, Mazumder PM, Parcha V. Modulatory effect of an isolated compound from Syzygiumcumini seeds on biochemical parameters of diabetes in rats. Int J Green Pharm. 2009;3:128-33
22. Ferrer JC, Favre C, Gomis RR, Fernaondez-Novell JM, Garcyoa-Rocha M, de la Iglesia N. Control of glycogendeposition. FEBS Lett. 2003;546:127-32
23. Geirch JE. Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc. 2003;78(4):447-56
24. Germoush MO, Mahmoud AM. Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines. J Cancer Res ClinOncol. 2014; 140(7):1103-9
25. Gold AH. The effect of diabetes and insulin on liver glycogen synthetase activation. J Biol Chem. 1970;245:903-5
26. Gomes AP, Duarte FV, Nunes P, Hubbard BP, Teodoro JS, Varela AT, Jones JG, Sinclair DA, Palmeira CM, Rolo AP. Berberine protects against high fat diet-induced dysfunction in muscle mitochondria by inducing SIRT1-dependent mitochondrial biogenesis. BiochimBiophysActa. 2012;1822(2):185-95
27. Gong P, Xu H, Zhang J, Wang Z. PPAR expression and its association with SOD and NF-κB in rats with obstructive jaundice. Biomed Res India. 2012;23:551-60
28. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D. Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res. 1992;52:4113-6
29. Haffner SM. Coronary heart disease in patients with diabetes. N Engl J Med. 2000; 342(14):1040-2
30. Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J. Muscle-specific PPARγ deletion causes insulin resistance. Nat Med. 2003;9:1491-7
31. Hsu YY, Chen CS, Wu SN, Jong YJ, Lo YC.Berberine activates Nrf2 nuclear translocation and protects against oxidative damage via a phosphatidylinositol 3-kinase/Akt-dependent mechanism in NSC34 motor neuron like cells. Eur J Pharm Sci. 2012;46(5):415-25
32. Hu Y, Davies GE. Berberine inhibits adipogenesis in high-fat dietinduced obesity mice. Fitoterapia. 2010;81(5):358-66
33. International Diabetes Federation (IDF). IDF Diabetes Atlas. 7thed. Brussels, Belgium: International Diabetes Federation; 2015. Available from: http://www.idf.org/diabetesatlas
34. Jain SK, Kannan K, Lim G, Matthew-Greer J, McVie R, Bocchini JA. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diabetes Care. 2003;26:2139-43
35. Jiang Q, Liu P, Wu X, Liu W, Shen X, Lan T, Xu S, Peng J, Xie X, Huang H. Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF-kappaB signaling pathway. Mol Cell Endocrinol. 2011;331(1):34-40
36. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia, 2003;46(1):3-19
37. Karthikesan K, Pari L, Menon VP. Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats. Gen PhysiolBiophys. 2010;29(1):23-30
38. Kim HE, Choi SE, Lee SJ, Lee JH, Lee YJ, Kang SS, Chun J, Kang Y. Tumour necrosis factor-alpha-induced glucose-stimulated insulin secretion inhibition in INS-1 cells is ascribed to a reduction of the glucose-stimulated Ca2+ influx. J Endocrinol. 2008;198:549-60
39. Kim SY, Kim HI, Park SK, Im SS, Li T, Cheon HG. Liver glucokinase can be activated by peroxisome proliferators-activated receptor-γ. Diabetes. 2004;53:S66-70
40. Kim WS, Lee YS, Cha SH, Jeong HW, Choe SS, Lee MR, Oh GT, Park HS, Lee KU, Lane MD, Kim JB. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am J PhysiolEndocrinolMetab. 2009;296(4):E812-9
41. Kushiyama A, Shojima N, Ogihara T, Inukai K, Sakoda H, Fujishiro M. Resistin-like molecule beta activates MAPKs, suppresses insulin signaling in hepatocytes, and induces diabetes, hyperlipidemia, and fatty liver in transgenic mice on a high fat diet. J Biol Chem. 2005;280:42016-25
42. Lang CH, Dobrescu C, Bagby GJ. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinol. 1992;130:43-52
43. Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55: 2256-64
44. Lefebvre P, Chinetti G, Fruchart JC, Staels B. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest. 2006;116;571-80
45. Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. ActaPharmacol Sin. 2004;25: 496-502
46. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY. Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest. 2002;110:851-60
47. Mahmoud AM, Ahmed OM, Ashour MB, Abdel-Moneim A. In vivo and in vitro antidiabetic effects of citrus flavonoids; A study on the mechanism of action. Int J Diabetes DevCtries. 2015;35(3):250-63
48. Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications. 2012;26(6):483-90
49. Mahmoud AM, Germoush MO, Soliman AS. Berberine attenuates isoniazid-induced hepatotoxicity by modulating peroxisome proliferator-activated receptor gamma, oxidative stress and inflammation. Int J Pharmacol 2014;10:451-60
50. Mahmoud AM. Hematological alterations in diabetic rats; role of adipocytokines and effect of citrus flavonoids. EXCLI J. 2013;12:647-57
51. Marklund S, Marklund G. Involvement of the Superoxide Anion Radical in the Autoxidation of Pyrogallol and a Convenient Assay for Superoxide Dismutase. Eur J Biochem. 1974;47(3):469-74
52. Matkovics B, Szabo L, Varga IS. Determination of enzyme activities in lipid peroxidation and glutathione pathways (in Hungarian). LaboratoriumiDiagnosztika. 1998;15:248-9
53. Mo C, Wang L, Zhang J, Numazawa S, Tang H, Tang X, Han X, Li J, Yang M, Wang Z, Wei D, Xiao H. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid. Redox Signal. 2014;20(4):574-88
54. Mojarad TB, Roghani M. The anticonvulsant and antioxidant effects of berberine in kainate-induced temporal lobe epilepsy in rats. Basic ClinNeurosci. 2014;5(2):124-30
55. Montgomery HAC, Dymock JF. The determination of nitrite in water. Analyst. 1961;86: 414-6
56. Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J PhysiolEndocrinolMetab. 2003;285:E106-115
57. Okuno Y, Matsuda M, Kobayashi H, Morita K, Suzuki E, Fukuhara A, Komuro R, Shimabukuro M, Shimomura I.Adipose expression of catalase is regulated via a novel remote PPARγ-responsive region. BiochemBiophys Res Commun 2008;366:698-704
58. Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, Rose DW, Willson TM, Rosenfeld MG, Glass CK. A SUMOylation dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature. 2005;437:759-63
59. Preuss HG, Jarrell ST, Scheckenbach R, Lieberman S, Anderson RA. Comparative effects of chromium, vanadium and gymnemasylvestre on sugar-induced blood pressure elevations in SHR. J Am CollNutr. 1998;17(2):116-23
60. Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003;111:225-30
61. Raju J, Gupta D, Rao AR, Yadava PK, Baquer NZ. Trigonellafoenumgraecum (fenugreek) seed powder improves glucose homeostasis in alloxan diabetic rat tissues by reserving the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem. 2001;224:45-51
62. Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. A new rat model of type 2 diabetes, the fat-fed, streptozotocin-treated rat. Metabolism. 2000;49: 1390-4
63. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev. 2001;17(3):189-212
64. Ryden M, Dicker A, van Harmelen V, Hauner H, Brunnberg M, Perbeck L. Mapping of early signaling events in tumor necrosis factor-alpha-mediated lipolysis in human fat cells. J Biol Chem. 2002;277:1085-91
65. Semple RK, Chatterjee, VK, O'Rahilly S. PPAR gamma and human metabolic disease. J Clin Invest. 2006;116(3):581-9
66. Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002;51:3391-9
67. Sharma AK, Bharti S, Goyal S, Arora S, Nepal S, Kishore K, Joshi S, Kumari S, Arya DS. upregulation of PPARγ by Aeglemarmelos ameliorates insulin resistance and β-cell dysfunction in high fat diet fed-streptozotocin induced type 2 diabetic rats. Phytother Res. 2011, 25,1457-65
68. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann ClinBiochem. 1969;6(1):24-7
69. Tripathi BK, Srivastava AK. Diabetes mellitus: complications and therapeutics. Med SciMonit. 2006;12(7):130-47
70. Tripathy D, Chavez AO. Defects in insulin secretion and action in the pathogenesis of type 2 diabetes mellitus. CurrDiab Rep. 2010;10:184-91
71. Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes. 2004;53(Suppl 3):S16-21
72. Xie X, Chang X, Chen L, Huang K, Huang J, Wang S, Shen X, Liu P, Huang H. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling. Mol Cell Endocrinol. 2013;381(1-2):56-65
73. Xie X, Li W, Lan T, Liu W, Peng J, Huang K, Huang J, Shen X, Liu P, Huang H. Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway. Endocr J. 2011;58(9):761-8
74. Xing LJ, Zhang L, Liu T, Hua YQ, Zheng PY, Ji G. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver. Eur J Pharmacol. 2011;668(3):467-71
75. Xu W, Yu L, Zhou W, Luo M. Resistin increases lipid accumulation and CD36 expression in human macrophages. BiochemBiophys Res Commun. 2006;351:376-82
76. Yamauci T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-6
77. Yang QH, Hu SP, Zhang YP, Xie WN, Li N, Ji GY, Qiao NL, Lin XF, Chen TY, Liu HT. Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats. Chin J Integr Med. 2011;17(3):205-11
78. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57:712-7
79. Yu HH, Kim KJ, Cha JD, Kim HK, Lee YE, Choi NY, You YO. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillinresistant Staphylococcus aureus. J Med Food. 2005;8:454-61
80. Zhang M, Lv X, Li J, Meng Z, Wang Q, Chang W, Li W, Chen L, Liu Y. Sodium caprate augments the hypoglycemic effect of berberinevia AMPK in inhibiting hepatic gluconeogenesis. Mol Cell Endocrinol. 2012;363(1-2):122-30
81. Zhao W, Xue R, Zhou ZX, Kong WJ, Jiang JD. Reduction of blood lipid by berberine in hyperlipidemic patients with chronic hepatitis or liver cirrhosis. Biomed Pharmacother. 2008;62(10):730-1
82. Zhou JY, Zhou SW. Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. Fitoterapia 2011;82(2):184-9
83. Zhou S, Zhou S, Tang J, Zhang K, Guang L, Huang Y, Xu Y, Ying Y, Zhang L, Li D. Protective effect of berberine on beta cells in streptozotocin-and high-carbohydrate/high-fat diet-induced diabetic rats. Eur J Pharmacol. 2009;606:262-8